Arthur A. Hancock

Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.

A. De Léan, Arthur A. Hancock, Robert J. Lefkowitz · Molecular Pharmacology · 1982 · 594 citations

Medicine, Pharmacology, Molecular Pharmacology +14

Pharmacological Properties of ABT-239 [4-(2-{2-[(2 R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist

Gerard B. Fox, Timothy A. Esbenshade, Jia Bao Pan et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 261 citations

Medicine, Neuroscience, Pharmacology +13

Quantitative Resolution of Beta-Adrenergic Receptor Subtypes by Selective Ligand Binding: Application of a Computerized Model Fitting Technique

Arthur A. Hancock, André DeLÉAN, Robert J. Lefkowitz · Molecular Pharmacology · 1979 · 227 citations

Medicine, Pharmacology, Biochemical Pharmacology +15

A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype.

Sheila M. Knepper, S A Buckner, M.E. Brune et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 131 citations

Medicine, Medicinal Chemistry, Pharmacology +14

4-(2-[2-(2(<i>R</i>)-Methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and Related 2-Aminoethylbenzofuran H₃ Receptor Antagonists Potently Enhance Cognition and Attention

Marlon Cowart, Ramin Faghih, Michael P. Curtis et al. · Journal of Medicinal Chemistry · 2004 · 122 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14